I’m so tired of seeing articles announcing a new migraine drug is in development, then discovering it’s an old drug with a different delivery system. These are not new drugs, even though press releases pretend that they are. The investigation and marketing of these new…
Please, please, please help get migraine included in the FDA’s exciting new patient-focused program by telling them how desperately migraine needs their attention. Inclusion would mean way more time and money spent on — and research and drug development for — this life-altering illness that…
Calcitonin gene-related peptide (CGRP) receptor antagonist MK-0974 holds promise as a migraine abortive, according to Phase II study results that will be presented at the American Headache Society‘s annual meeting this week. The drug works by blocking CGRP, a brain chemical that is important for…